Márquez Paola H Ponte, Torres Olga H, San-José Anonio, Vidal Xavier, Agustí Antonia, Formiga Francesc, López-Soto Alfonso, Ramírez-Duque Nieves, Fernández-Moyano Antonio, Garcia-Moreno Juana, Arroyo Juan A, Ruiz Domingo
Internal Medicine Service, Hypertension and Vascular Risk Unit, Hospital de la Santa Creu i Sant Pau/Universidad Autónoma de Barcelona, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, Barcelona, CP 08041, Spain.
Internal Medicine Service, Geriatric Unit, Hospital Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Drugs Aging. 2017 Jun;34(6):453-466. doi: 10.1007/s40266-017-0452-z.
INTRODUCTION: Previous studies of antihypertensive treatment of older patients have focused on blood pressure control, cardiovascular risk or adherence, whereas data on inappropriate antihypertensive prescriptions to older patients are scarce. OBJECTIVES: The aim of the study was to assess inappropriate antihypertensive prescriptions to older patients. METHODS: An observational, prospective multicentric study was conducted to assess potentially inappropriate prescription of antihypertensive drugs, in patients aged 75 years and older with arterial hypertension (HTN), in the month prior to hospital admission, using four instruments: Beers, Screening Tool of Older Person's Prescriptions (STOPP), Screening Tool to Alert Doctors to the Right Treatment (START) and Assessing Care of Vulnerable Elders 3 (ACOVE-3). Primary care and hospital electronic records were reviewed for HTN diagnoses, antihypertensive treatment and blood pressure readings. RESULTS: Of 672 patients, 532 (median age 85 years, 56% female) had HTN. 21.6% received antihypertensive monotherapy, 4.7% received no hypertensive treatment, and the remainder received a combination of antihypertensive therapies. The most frequently prescribed antihypertensive drugs were diuretics (53.5%), angiotensin-converting enzyme inhibitors (ACEIs) (41%), calcium antagonists (32.2%), angiotensin receptor blockers (29.7%) and beta-blockers (29.7%). Potentially inappropriate prescription was observed in 51.3% of patients (27.8% overprescription and 35% underprescription). The most frequent inappropriately prescribed drugs were calcium antagonists (overprescribed), ACEIs and beta-blockers (underprescribed). ACEI and beta-blocker underprescriptions were independently associated with heart failure admissions [beta-blockers odds ratio (OR) 0.53, 95% confidence interval (CI) 0.39-0.71, p < 0.001; ACEIs OR 0.50, 95% CI 0.36-0.70, p < 0.001]. CONCLUSION: Potentially inappropriate prescription was detected in more than half of patients receiving antihypertensive treatment. Underprescription was more frequent than overprescription. ACEIs and beta-blockers were frequently underprescribed and were associated with heart failure admissions.
Br J Clin Pharmacol. 2009-12
Singapore Med J. 2015-5
Can Fam Physician. 1998-2
Int J Environ Res Public Health. 2022-12-31
J Hum Hypertens. 2022-4
Medicina (Kaunas). 2021-2-9
N Engl J Med. 2015-11-26
J Intern Med. 2015-10-26
Med Clin (Barc). 2014-8-4